Effects of Hemp-Derived Cannabinoids on Menopause Symptoms

Part of paid clinical trials in Pullman, Washington.

Sponsor
Washington State University
Study ID
NCT07393672
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
40 Years - 60 Years
Healthy Volunteers
Accepted

Interventions

  • Hemp-derived cannabinoids — DRUG
    Participants will be administered a legal product with hemp-derived cannabinoids and terpenes.
  • Placebo — DRUG
    Participants will be administered a placebo

Study Details

The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.

Key Dates

Start date
Feb 11, 2026
Status verified
Mar 2026
Primary completion
Nov 10, 2026
Completion
Nov 10, 2026

Study Design

Enrollment
104 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Placebo Comparator: Placebo Arm
    Participants in this arm will receive a placebo.
  • Active Comparator: Active Arm
    Participants in this arm will receive an active product.

Primary Outcome Measure

Depression Monthly Assessment: Center for Epidemiologic Studies Depression Scale (CES-D) [ Time Frame: The survey will be completed shortly after the monthly Zoom sessions, during four different sessions. They will occur at approximately week 1, 5, 9, and 13. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington State University, Dept of PsychologyPullmanWashington99164
Carrie Cuttler, PhD
[email protected]
509-592-0151
Carrie Cuttler, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Pullman, WA

By condition
Menopause
By specialty
Women's healthFertility
By research site
Washington State University, Dept of Psychology· Pullman, WA

Related Studies